articleTop 1% cited
EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2016
European Urology · 2016 · Vol. 71(3) · pp. 447–461
Marko Babjuk✉(Charles University)Andreas Böhle(Helios Kliniken)Maximilian Burger(University of Regensburg)Otakar Čapoun(Charles University)Daniel L. Cohen(Imperial College London)Éva Compérat(Sorbonne Université)Virginia Hernández(Hospital Universitario Fundación Alcorcón)Eero Kaasinen(Hyvinkää Hospital)Joan Palou(Puigvert Foundation)Morgan Rouprêt(Onco-Urologie Prédictive)Bas W.G. van Rhijn(The Netherlands Cancer Institute)Shahrokh F. Shariat(Vienna General Hospital)Viktor Soukup(Charles University)Richard SylvesterRichard Zigeuner(Medical University of Graz)
Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology StudiesUrological Disorders and TreatmentsMedicineBladder cancerCystoscopyCarcinoma in situUrologyUrothelial carcinomaCarcinomaCancerOncologyInternal medicine
MeSH terms
Adjuvants, ImmunologicAdministration, IntravesicalAntineoplastic AgentsBCG VaccineUrinary BladderUrinary Bladder NeoplasmsCarcinoma in SituCarcinoma, Transitional CellCystoscopyEuropeHumansMuscle, SmoothNeoplasm InvasivenessNeoplasm StagingSocieties, Medical
Citations
2,278
FWCI
334.23
field-weighted impact
References
126
Percentile
100%
vs. same field & year
Citations per year
Cited by
Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends
European Urology · 2016 · 2,614 citations
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Carcinoma: 2017 Update
European Urology · 2017 · 763 citations
European Association of Urology Guidelines on Upper Urinary Tract Urothelial Cell Carcinoma: 2015 Update
European Urology · 2015 · 1,341 citations
Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries
CA A Cancer Journal for Clinicians · 2021 · 110,575 citations
References
Intravesical bacille calmette-guérin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression
Urology · 2004 · 458 citations
Predicting Recurrence and Progression in Individual Patients with Stage Ta T1 Bladder Cancer Using EORTC Risk Tables: A Combined Analysis of 2596 Patients from Seven EORTC Trials
European Urology · 2006 · 2,943 citations
Intravesical Bacillus Calmette-Guerin Reduces the Risk of Progression in Patients with Superficial Bladder Cancer: A Meta-analysis of the Published Results of Randomized Clinical Trials
The Journal of Urology · 2002 · 1,296 citations
Variability in the Recurrence Rate at First Follow-up Cystoscopy after TUR in Stage Ta T1 Transitional Cell Carcinoma of the Bladder: A Combined Analysis of Seven EORTC Studies
European Urology · 2002 · 678 citations
Bladder tumor markers beyond cytology: International Consensus Panel on bladder tumor markers
Urology · 2005 · 427 citations
An Individual Patient Data Meta-Analysis of the Long-Term Outcome of Randomised Studies Comparing Intravesical Mitomycin C versus Bacillus Calmette-Guérin for Non–Muscle-Invasive Bladder Cancer
European Urology · 2009 · 650 citations
MAINTENANCE BACILLUS CALMETTE-GUERIN IMMUNOTHERAPY FOR RECURRENT TA, T1 AND CARCINOMA IN SITU TRANSITIONAL CELL CARCINOMA OF THE BLADDER: A RANDOMIZED SOUTHWEST ONCOLOGY GROUP STUDY
The Journal of Urology · 2000 · 1,298 citations
Epidemiology and Risk Factors of Urothelial Bladder Cancer
European Urology · 2012 · 2,155 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.